Alexsandro M. Carvalho

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Trastuzumab (Herceptin®) is an FDA-approved therapeutic antibody currently employed in the treatment of metastatic stages of breast cancer. Herein, we propose a simple, fast and cost-effective methodology to conjugate trastuzumab with 22-mer 5' thiol-modified oligonucleotides using a bifunctional crosslinker. The conjugates were successfully characterized(More)
  • 1